IRCT20230315057726N1招募中3 期
Comparing the effectiveness ofEmpagliflozin with Metformin in controlling Diabetes Mellitus in patients with post-organ transplant diabetes
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •At least 6 months have passed since the patient's transplant
- •No previous history of diabetes and use of any blood sugar-lowering medication
- •Diagnosing diabetes according to the criteria of the American Diabetes Association
- •HbA1c>6.5%
排除标准
- •Rejection of the transplanted organ in the patient
- •Transplanted organ failure
- •Age less than 18 years
- •Any contraindication related to empagliflozin (allergy to the drug or its components, dialysis, diabetic ketoacidosis, hospitalization)
- •The patient's unwillingness to participate in the study
- •BMI above 40
- •Severe liver failure (enzymes more than 3 times the normal limit)
- •or renal failure (creatinine more than 2), creatinine clearance below 60
- •Any contraindication related to Metformin (allergy to the drug or its components, dialysis, diabetic ketoacidosis, hospitalization)
研究者
相似试验
尚未招募
3 期
Comparison of therapeutic effect of Empagliflozin (Gloripa) and Sitagliptin (Ziptin) on type 2 Diabetic patientsIRCT20200810048355N1Vice Chancellor for Research, Islamic Aazad University, Najafabad branch128
尚未招募
2 期
The effect of Empagliflozin on nonalcoholic fatty liver disease in non-diabetic patientson alcoholic fatty liver disease.Nonalcoholic steatohepatitis [NASH]K75.81IRCT20190122042450N1Iran University of Medical Sciences100
招募中
4 期
The effect of empagliflozin in patients with idiopathic edemaIdiopathic edema.Edema, unspecifiedR60.9IRCT20230314057712N1Ahvaz University of Medical Sciences70
招募中
3 期
Effect of Empagliflozin in PrediabetesCondition 1: Impaired fasting glucose. Condition 2: Impaired glucose tolerance.Impaired fasting glucoseImpaired glucose tolerance (oral)R73.01R73.02IRCT20220902055858N1Shahre-kord University of Medical Sciences90
招募中
1 期
Investigating the effect of empagliflozin and melijent in chronic kidney failure patientsDiabetic patients.Type 2 diabetes mellitus with kidney complicationsE11.2IRCT20230607058409N1Shahid Beheshti University of Medical Sciences150